Diazepam-omeprazole inhibition interaction: An in vitro investigation using human liver microsomes

British Journal of Clinical Pharmacology

Volumn 42, Issue 2, 1996, Pages 157-162

  Zomorodi, K ^a   Houston, J B ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CYP2C19; CYP3A; Diazepam; Drug interactions; Human microsomes; In vitro metabolism; Omeprazole; Omeprazole sulphone

Indexed keywords

CYTOCHROME P450; DIAZEPAM; DRUG METABOLITE; NORDAZEPAM; OMEPRAZOLE; OMEPRAZOLE SULFONE; OXAZEPAM; TEMAZEPAM;

ARTICLE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG METABOLISM; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER MICROSOME; PRIORITY JOURNAL;

EID: 0030016683     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03563.x     Document Type: Article

References (24)

1. Howden CW. Clinical pharmacology of omeprazole. Clin Pharmacokin 1991; 20 : 38-49.
2. Regårdh CG, Gabrielsson M, Hoffmann K-J, Löfberg I, Skånberg I. Pharmacokinetics and metabolism of omeprazole in animals and man - an overview. Scand J Gastroenterol 1985; 20: 79-94.
3. Andersson T, Miners JO, Veronese ME, Birkett DJ. Identification of human liver cytochrome P450 isoforms mediating secondary omeprazole metabolism. Br J Clin Pharmacol 1994; 37 : 597-604.
4. Diaz D, Fabre I, Daujat M, et al. Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450. Gastroenterol 1990; 99: 737-747.
5. Andersson T. Omeprazole drug interaction studies. Clin Pharmacokin 1991; 21: 195-212.
6. Schouler L, Dumas F, Couzigou P, Janvier G, Winnock S, Saric J. Omeprazole-cyclosporin interaction. Am J Gastroenterol 1991; 86: 1097.
7. Blohmé I, Idström J-P, Andersson T. A study of interaction between omeprazole and cyclosporin in renal transplant patients. Br J Clin Pharmacol 1993; 35: 156-160.
8. Gugler R, Jensen JC. Omeprazole inhibits oxidative drug metabolism. Gastroenterol 1985; 89: 1235-1241.
9. Bachmann KA, Sullivan TJ, Jauregui L, Reese JH, Miller K, Levine L. Absence of an inhibitory effect of omeprazole and nizatidine on phenytoin disposition, a marker of CYP2C activity. Br J Clin Pharmacol 1993; 36: 380-382.
10. Andersson T, Andrén K, Cederberg C, Edvardsson G, Heggelund A, Lundborg P. Effect of omeprazole and cimetidine on plasma diazepam levels. Eur J Clin Pharmacol 1990; 39: 51-54.
11. Andersson T, Cederberg C, Edvardsson G, Heggelund A, Lundborg P. Effect of omeprazole treatment on diazepam plasma levels in slow versus normal rapid metabolizers of omeprazole. Clin Pharmacol Ther 1990; 47: 79-85.
12. Chenery RJ, Ayrton A, Oldham HG, et al. Diazepam metabolism in cultured hepatocytes from rat, rabbit, dog, guinea pig and man. Drug Metab Disp 1987; 15: 312-317.
13. Bertilsson L, Henthorn TK, Sanz E, Tybring G, Säwe J, Villén T. Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquine, hydroxylation phenotype. Clin Pharmacol Ther 1989; 45: 348-355.
14. Inaba T, Jurima M, Mahon WA, Kalow W. In vitro inhibition studies of two isoenzymes of human liver cytochrome P-450. Mephenytoin p-hydroxylase and sparteine monooxygenase. Drug Metab Disp 1985; 13: 443-448.
15. Beischlag TV, Kalow W, Mahon WA, Inaba T. Diazepam metabolism by rat and human liver in vitro : inhibition by mephenytoin. Xenobiotica 1992; 22: 559-567.
16. Forrester LM, Henderson CJ, Glancey MJ, et al. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics. Biochem J 1992; 281: 359-368.
17. Yasumori T, Nagata K, Yang SK, et al. Cytochrome P450 mediated metabolism of diazepam in human and rat: involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner. Pharmacogenetics 1993; 3: 291-301.
18. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 1951; 193: 265-275.
19. Reilly PEB, Thompson DA, Mason SR, Hooper WD. Cytochrome P450IIIA enzymes in rat liver microsomes: involvement in C3-hydroxylation of diazepam and nordazepam but not N-delakylation of diazepam and temazepam. Mol Pharmacol 1990; 37: 767-774.
20. Andersson T, Miners JO, Veronese ME, Birkett DJ. Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms. Br J Clin Pharmacol 1994; 38: 131-137.
21. 3-hydroxylation. Drug Metab Disp 1988; 16: 605-608.
22. Maurice M, Pichard L, Daujat M, Fabre I, Joyeux H, Domergue J, Maurel P. Effect of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture. FASEB J 1992; 752-758.
23. Zomorodi K, Houston JB. Effect of omeprazole on diazepam disposition in the rat: in vitro and in vivo studies. Pharm Res 1995; 1642-1646.
24. Houston JB. Drug metabolite kinetics. Pharmacol Ther 1982; 15: 521-552.